BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.55 Cr | ₹-2.44 Cr | ₹2.71 Cr | ₹0.37 Cr | ₹0.09 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BAL PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹0.55 Cr |
| Mar2025 | ₹-2.44 Cr |
| Mar2024 | ₹2.71 Cr |
| Mar2023 | ₹0.37 Cr |
| Mar2022 | ₹0.09 Cr |
How is Net Cash Inflow / Outflow of BAL PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.55 Cr | Positive | |
| Mar2025 | ₹-2.44 Cr | Negative | |
| Mar2024 | ₹2.71 Cr | 624.33 | |
| Mar2023 | ₹0.37 Cr | 320.22 | |
| Mar2022 | ₹0.09 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹159.4 Cr | -6.7% | 17.8% | 15.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -6.7% |
17.8% |
15.3% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses